SURAKSHA DIAGNOSTIC   
                    
                    
                                                         
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
SURAKSHA DIAGNOSTIC Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 15.49 | -0.51 | -0.68 | 0.49 | 0.86 | 
What is the latest EV/Core EBITDA ratio of SURAKSHA DIAGNOSTIC ?
| Year | EV/Core EBITDA | 
|---|---|
| Mar2025 | 15.49 | 
| Mar2024 | -0.51 | 
| Mar2023 | -0.68 | 
| Mar2022 | 0.49 | 
| Mar2021 | 0.86 | 
How is EV/Core EBITDA of SURAKSHA DIAGNOSTIC Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | 15.49 | Positive | |
| Mar2024 | -0.51 | Negative | |
| Mar2023 | -0.68 | Negative | |
| Mar2022 | 0.49 | -43.02 | |
| Mar2021 | 0.86 | - | |
Other Financial Ratios of SURAKSHA DIAGNOSTIC
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate  | Margin  Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare EV/Core EBITDA ratio of peers of SURAKSHA DIAGNOSTIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SURAKSHA DIAGNOSTIC | ₹1,647.1 Cr | -1.7% | 6.3% | NA | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹112,510.0 Cr | -0.7% | 5.1% | 10% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹111,467.0 Cr | -2.8% | 3.1% | 15.3% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹77,787.1 Cr | -2.6% | 4.1% | 70.1% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹36,492.7 Cr | 0.6% | 3% | 42.3% | Stock Analytics | |
| GLOBAL HEALTH | ₹34,290.9 Cr | -5.9% | -2.3% | 22.8% | Stock Analytics | |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| SURAKSHA DIAGNOSTIC |    -1.7%  | 
                            
                     
                     6.3%  | 
                     
                     | 
                    
| SENSEX |    -0.9%  |    
                      
                    
                     4.6%  | 
                     
                     5%  | 
                    
You may also like the below Video Courses